Abstract: Provided is a barrier film, comprising a base layer and an inorganic layer including a first region and a second region, which have different elemental contents (atomic %) of Si, N, and O from each other as measured by XPS, and having a compactness expressed through an etching rate of 0.17 nm/s in the thickness direction for an Ar ion etching condition to etch Ta2O5 at a rate of 0.09 nm/s, wherein the second region has a higher elemental content of N than that of the first region, and the second region has a thickness of 10% or more relative to the total thickness of the inorganic layer. The barrier film has excellent barrier properties and optical properties and can be used for electronic products which are sensitive to moisture and the like.

Abstract: A storage device may search for a target page among pages included in a first memory block of a plurality of memory blocks each including a plurality of pages, and when an uncorrectable error occurs while reading data stored in the target page, may overwrite dummy data into the target page and then store address information indicating a location of the target page in a second memory block among the plurality of memory blocks.

Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: Disclosed are a crystallization process of an oxide semiconductor, a method of manufacturing a thin film transistor including the same, a thin film transistor, a display panel, and an electronic device. The crystallization process of an oxide semiconductor includes forming an amorphous oxide semiconductor layer on a substrate, forming a crystallization auxiliary layer including a light absorbing inorganic material on the amorphous oxide semiconductor layer, and annealing the crystallization auxiliary layer to crystallize the amorphous oxide semiconductor layer.

Abstract: A camera module is provided. The camera module includes a lens barrel in which at least one lens is installed; and a lens holder to which the lens barrel is fixedly installed, wherein one of the lens holder and the lens barrel is provided with a coupling protrusion, and the other thereof is provided with a coupling groove into which the coupling protrusion is inserted, the lens holder is provided with a support portion that supports one end portion of the lens barrel, wherein the one end portion of the lens barrel is disposed between the coupling protrusion and the support portion, and the support portion of the lens holder elastically supports the lens barrel in an optical axis direction.

Abstract: Disclosed is a method of manufacturing a blank for hot stamping, which includes forming a plated layer on a steel plate by immersing the steel plate in a plating bath including aluminum and silicon; and heating the steel plate on which the plated layer is formed at a first temperature for a first time period.

Abstract: The present disclosure provides a compound of a specific chemical structure binding to MLKL or having an MLKL inhibiting or degrading activity, or pharmaceutically acceptable salts thereof. The present disclosure provides a composition comprising such compound or pharmaceutically acceptable salts thereof. The present disclosure provides the pharmaceutical use of the compound according to the present invention, salts thereof, and a composition comprising same for treating or preventing MLKL-related diseases. The present disclosure also provides a method for treating or preventing MLKL-related diseases, comprising administering to a subject in need of treatment an effective amount of a compound according to the present invention, salts thereof, or a composition comprising same.

Abstract: A light emitting display device can include a display panel configured to display an image; a driver configured to drive the display panel; a controller configured to control the driver; and a defect sensing circuit configured to sense a current through a driving voltage line transmitting a driving voltage for driving of the display panel, and output a sensing value based on the current for determining whether an element in a subpixel of the display panel is defective.

Abstract: A lens module is provided. The lens module includes a plurality of lenses disposed along an optical axis, a lens barrel configured to accommodate the plurality of lenses, and a fixing member configured to fix at least one of the plurality of lenses to the lens barrel. The lens barrel includes a through-hole which accommodates a portion of the fixing member, a first end of the fixing member protrudes outwardly of the through-hole, and a diameter of the first end of the fixing member is greater than a diameter of the through-hole.

Abstract: Disclosed herein are an apparatus and method for processing cloud streaming low latency playback. The cloud streaming low latency playback processing method in a client apparatus according to an embodiment of the present disclosure may further include checking each piece of time information about decoded audio data and decoded video data to determine whether a time difference between the decoded audio data and video data, and adjusting one of a decoding speed of audio data and a decoding speed of video data when a time difference is greater than a preset threshold value.

Abstract: The present invention relates to a composition comprising vascular endothelial progenitor cells and mesenchymal stem cells as active ingredients for prevention or treatment of occlusive vascular diseases or complications thereof. Since it was found that vascular endothelial progenitor cells and mesenchymal stem cells remarkably improved vascularization ability upon application thereof in combination, the present invention has the effect of providing a new cell therapy product for prevention or treatment of occlusive vascular diseases or ulcers resulting therefrom, and a preparation method therefore.

Abstract: Provided is an adhesive composition including an ethylene-acrylic acid copolymer and a post-consumer recycled resin (PCR), wherein the ethylene-acrylic acid copolymer has a melt index (190° C., 2.16 kg, ASTM D1238) of 1 to 30 g/10 min, and the PCR has a melt index (190° C., 2.16 kg, ASTM D1238) of 1 to 10 g/10 min, and a preparation method thereof, which can have excellent processability, low gel content, and excellent adhesive strength by easily distinguishing a certain level of PCR resin by a capillary rheometer and mixing the PCR resin with an ethylene-acrylic acid copolymer.

Abstract: An aperture module includes: a base; a rotating plate rotatably disposed on the base; and blades configured to form an incident hole and move by rotation of the rotating plate to change a size of the incident hole. The blades are disposed in an opening disposed inside the rotating plate.

Abstract: A substrate processing apparatus and a substrate processing method are provided, which can improve the yield by minimizing the occurrence of stains. The substrate processing method includes forming on the substrate a plurality of ink patterns spaced apart from each other by jetting ink onto the substrate by using a plurality of nozzles, calculating the density of each of the plurality of ink patterns, and selecting at least one nozzle for jetting ink into one pixel area based on respectively calculated densities of the plurality of ink patterns.

Abstract: A circuit for preventing power imbalance of a resonance-type power converter is proposed. The circuit may include a rectifier converting input alternating current (AC) into direct current (DC) and frequency-controlled first and second resonant converter modules configured to receive an output voltage of the rectifier divided into two stages. The circuit may further include a controller outputting a first frequency command for controlling a frequency of a pulse width modulation (PWM) signal supplied to a switching element of a first switching unit of the first resonant converter module. The circuit may further include a frequency compensator compensating for the first frequency command and then outputting a second frequency command for controlling a frequency of a PWM signal supplied to a switching element of a second switching unit of the second resonant converter module, so as to eliminate power imbalance between the first and second resonant converter modules.

Abstract: Provided is a barrier film comprising a base layer, and an inorganic layer including Si, N, and O, and including a first region and a second region, which have different elemental contents (atomic %) of Si, N, and O from each other as measured by XPS, wherein the film has a water vapor transmission rate of 5.0×10?4 g/m2·day or less as measured under conditions of a temperature of 38° C. and 100% relative humidity after being stored at 85° C. and 85% relative humidity conditions for 250 hours, or wherein the inorganic layer has a compactness expressed through an etching rate of 0.17 nm/s in the thickness direction for an Ar ion etching condition to etch Ta2O5 at a rate of 0.09 nm/s. The barrier film has excellent barrier properties and optical properties and can be used for electronic products that are sensitive to moisture and the like.

Abstract: Provided is a display panel including a base layer including a first pixel region, a second pixel region at least partially spaced apart from the first pixel region in a first direction, and a non-pixel region adjacent to the first and second pixel regions, a pixel defining layer having first and second pixel openings defined in the pixel defining layer and respectively corresponding to the first and second pixel regions, and a light-emitting portion including a charge generation layer, wherein the pixel defining layer includes at least one first valley region and at least one first non-valley region disposed on a first virtual line completely enclosing the first pixel opening and at least one second valley region and at least one second non-valley region disposed on a second virtual line completely enclosing the second pixel opening.

Abstract: The present disclosure relates to a method and apparatus for predicting application service response time in a communication system. Particularly, the present disclosure relates to a method, apparatus and system for predicting response time required to provide an application service to a user in response to the user's request of the application service in a server of a communication system. A method for predicting application service response time according to an embodiment of the present disclosure includes: data collection for collecting network data associated with a user application service, in response to a request for the application service by a user device; and data analysis for performing, by utilizing the collected data, a response time predictive analysis, in order to predict a user's application service response time. The data analysis selects an optimal prediction model by initially applying a response time prediction model and testing the initial prediction model that is applied.

Abstract: A display apparatus including a display and a supporter. The supporter being mounted on the display and configured to support the display and rotate the display module between a first position and a second position. The supporter including a drive motor, a first gear, and a detection sensor. The drive motor configured to supply a driving force to rotate the display. The first gear configured to rotate together with the display by receiving the driving force from the drive motor. The detection sensor configured to detect a rotation amount of a second gear configured to rotate in with the first gear.

Abstract: Provided is a vaccine composition for preventing respiratory syncytial virus (RSV) infection, which is in the form of a liposome formulation including a RSV antigen, monophosphoryl lipid A (MLA), and/or a cobalt-porphyrin-phospholipid (CoPoP) conjugate. The vaccine composition exhibits excellent vaccine efficacy from a RSV antigen with enhanced immunogenicity and a combination of immune adjuvants for enhancing immune activity and antigen presentation.